Bristol-Myers Squibb Pays $14M Over Alleged China Bribes
By Max Stendahl · October 5, 2015, 1:24 PM EDT
Bristol-Myers Squibb Co. on Monday agreed to pay $14 million to settle allegations by the U.S. Securities and Exchange Commission that its representatives in China bribed state-owned and state-controlled hospitals to...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login